dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada Clinical Use of Inhibitors The pharmacology of DPP-4 inhibitors

Neurohormonal modulation GLP-1 RAs may modulate BP by influencing neurohormonal activity and autonomic tone

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

Conclusion As newer GLP-based therapies continue to emerge, a clearer understanding of their effects on BP may inform more integrated approaches to cardiometabolic care

GLP-1 plays a crucial role in stimulating insulin release from pancreatic islets in response to elevated glucose levels following food consumption [8]

These medications also impact hunger hormones, so people taking them dont think about food as much, which makes it easier to make healthier food choices

By application, the type 2 diabetes mellitus segment captured the highest market share of 60% in 2025